Loading...
Market
Public perception shift on mRNA vaccines post Pfizer/BioNTech allegations by Dec 31, 2025?
1
Resolution / Starting Odds
Increased trust in mRNA vaccines • 25%
Decreased trust in mRNA vaccines • 25%
Trust remains unchanged • 25%
Mixed opinions • 25%
Public opinion polls or surveys conducted by reputable organizations
Story
Study Calls for Moratorium on Pfizer/BioNTech COVID-19 mRNA Injections Due to 300% DNA Contamination
Dec 3, 2024, 04:12 PM
A recent study has called for an immediate moratorium on COVID-19 mRNA injections, specifically targeting Pfizer/BioNTech's vaccines. The study claims that the injections contain alarming levels of DNA contamination, exceeding regulatory limits by over 300%. This finding aligns with previous research that raised concerns about the safety and efficacy of these vaccines. Additionally, the so-called 'Pfizer Papers' have surfaced, alleging significant vaccine-related harm and cover-ups, including claims of suppressed safety trials and adverse effects. These revelations have sparked a renewed debate over the safety of mRNA vaccines and the regulatory oversight surrounding their approval and distribution.
View original story
Similar markets
Increased trust • 25%
Decreased trust • 25%
No significant change • 25%
Mixed responses • 25%
Mostly positive • 25%
Mixed • 25%
Mostly negative • 25%
Unchanged • 25%
Increase trust • 25%
Decrease trust • 25%
No significant change • 25%
Mixed impact • 25%
Increased vaccine hesitancy • 25%
No change in public opinion • 25%
Increased trust in vaccines • 25%
Mixed reactions • 25%
Increased vaccine hesitancy • 25%
No significant change • 25%
Increased trust in vaccines • 25%
Public divided • 25%
Increased trust in vaccines • 25%
Decreased trust in vaccines • 25%
Increased demand for transparency • 25%
Indifference • 25%
More negative perception • 25%
More positive perception • 25%
No significant change • 25%
Other • 25%
Mostly negative • 25%
Mostly positive • 25%
Balanced reporting • 25%
Limited coverage • 25%
Majority positive • 25%
Majority negative • 25%
Evenly split • 25%
Insufficient data • 25%
More positive • 33%
More negative • 33%
No significant change • 33%
Mostly positive • 25%
Mostly negative • 25%
Mixed • 25%
Indifferent • 25%